Chronic exposure to Delta9-tetrahydrocannabinol downregulates oxytocin and oxytocin-associated neurophysin in specific brain areas

Molecular and Cellular Neurosciences
Elena ButovskyZvi Vogel

Abstract

Cannabinoids are widely abused drugs. Our goal was to identify genes modulated by Delta9-tetrahydrocannabinol (Delta9-THC) treatment. We found that chronic administration of Delta9-THC (1.5 mg/kg/day, i.p.; 7 days) to rats, downregulates the expression of oxytocin-neurophysin (OT-NP) mRNA and of OT and oxytocin-associated NP (NPOT) immunoreactivity in nucleus accumbens (NAc) and ventral tegmental area (VTA), brain areas involved in reward and addiction. Real-time PCR revealed a 60% and 53% reduction of OT-NP mRNA in NAc and VTA, respectively, under chronic treatment, while no changes were observed in NAc after 24 h. Immunohistochemistry showed a large decrease in number of OT and NPOT-stained fibers in NAc (by 59% and 52%, respectively) and VTA (by 50% and 56%, respectively). No changes in cell staining were observed in the paraventricular nucleus and supraoptic nucleus. As OT is known to inhibit development of drug tolerance and attenuate withdrawal symptoms, we suggest that OT downregulation could play a role during the establishment of the chronic effects of Delta9-THC.

References

Jan 1, 1992·Clinical Neuropharmacology·G K AghajanianJ H Kogan
Oct 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·G F JirikowskiF E Bloom
Sep 15, 1989·The Journal of Comparative Neurology·A R CafféF W Van Leeuwen
Mar 1, 1988·Neuroscience·M Castel, J F Morris
Dec 1, 1984·Cellular and Molecular Neurobiology·Y Ben-BarakH Gainer
Jan 25, 1980·Science·M J BrownsteinH Gainer
Jan 1, 1995·Annual Review of Pharmacology and Toxicology·A C Howlett
Jul 15, 1993·The Journal of Comparative Neurology·P KrémarikM E Stoeckel
Feb 1, 1996·Neuroscience Research·R YoshimuraH Kiyama
Sep 1, 1996·Brain Research. Molecular Brain Research·N Matus-LeibovitchB Attali
Feb 1, 1996·Cell Biology International·R G WilsonA M Zimmerman
Feb 21, 1997·Neuroscience Letters·M C Sañudo-PeñaJ M Walker
Jan 1, 1994·Psychoneuroendocrinology·Z Sarnyai, G L Kovács
Jan 1, 1997·Pharmacology & Therapeutics·R G Pertwee
Jan 30, 1999·Psychoneuroendocrinology·G L KovácsG Szabó
Feb 12, 1999·Neurobiology of Disease·E L Gardner, S R Vorel
Jan 11, 2000·Behavioural Brain Research·A ArvanitogiannisP Shizgal
Jan 4, 2001·Molecular Genetics and Metabolism·H Shojo, Y Kaneko
Mar 17, 2001·Nature Reviews. Neuroscience·E J Nestler
Mar 17, 2001·Nature Reviews. Neuroscience·T R Insel, L J Young
Apr 3, 2001·The Journal of Comparative Neurology·M HallbeckA Blomqvist
Jun 21, 2001·Proceedings of the National Academy of Sciences of the United States of America·E MohrD Richter
Aug 8, 2001·The European Journal of Neuroscience·M PistisG L Gessa
Sep 6, 2001·Hormones and Behavior·L J YoungT R Insel
Oct 3, 2001·The American Journal on Addictions·E J Nestler
Jan 1, 1992·The European Journal of Neuroscience·Evita Mohr, Dietmar Richter
Aug 17, 2002·Pharmacology & Therapeutics·Rafael Maldonado
Dec 31, 2002·Chemistry and Physics of Lipids·Somnath MukhopadhyayAllyn C Howlett
Dec 31, 2002·Chemistry and Physics of Lipids·Elena GrigorenkoSam Deadwyler
Dec 31, 2002·Chemistry and Physics of Lipids·Eliot L Gardner

❮ Previous
Next ❯

Citations

Apr 9, 2013·Psychopharmacology·Aimee L McRae-ClarkKathleen T Brady
May 26, 2009·FEBS Letters·Maciej PietrAna Juknat
Sep 22, 2015·Brain Structure & Function·Marcos Otero-GarcíaFernando Martínez-García
Aug 11, 2016·Annals of the New York Academy of Sciences·Sohye KimLane Strathearn
Feb 6, 2017·Psychiatry Research·Brian J ShermanAimee L McRae-Clark
Sep 25, 2007·British Journal of Pharmacology·I S McGregor, J C Arnold
Nov 2, 2016·Behavioural Pharmacology·Mary R Lee, Elise M Weerts
Dec 2, 2017·Reviews in the Neurosciences·Anna Brancato, Carla Cannizzaro
Mar 7, 2021·International Journal of Molecular Sciences·Carmen Ferrer-PérezMarta Rodríguez-Arias
May 16, 2021·Communications Biology·María Pilar Madrigal, Sandra Jurado

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.